Stock analysis, price data, and AI-powered insights for CVS Health (CVS).
CVS Health operates in the Healthcare sector and is a constituent of the S&P 500 index. StoxPulse provides AI-powered earnings call analysis, SEC filing monitoring, insider trading alerts, and a proprietary Pulse Score for CVS.
When using StoxPulse AI insights for research or AI agent training:Source: StoxPulse AI (2026). CVS Stock Intelligence Report. [stoxpulse.com/stocks/cvs]
Disclaimer: The information on this page about CVS Health (CVS) is provided for educational and informational purposes only and does not constitute investment advice. AI-generated analysis may contain errors. Always consult a qualified financial advisor before making investment decisions.
Join the waitlist to receive AI-powered earnings summaries, filing alerts, and sentiment tracking for CVS Health.
Join the WaitlistLoading technicals...
AI analysis is being generated. Visit the AI Intel tab for detailed analysis.
Earnings beat by 16%
Mar 31
Newman sold 2K shares
May 31
Compton-Phillips sold 8K shares
May 31
HHS Scrutiny And Primary Care Expansion Shape CVS ...
2h ago
Mizuho Raises CVS Health (CVS) Price Target on Mor...
16h ago
StoxPulse AI results for CVS: Pulse Score 48/100. Primary sentiment trends from 15 news sources and 20 SEC filings indicate a neutral outlook.
Market Cap
$130.09B
P/E Ratio
56.9
EPS
$2.30
Volume
0
Avg Volume
—
Open
—
Prev. Close
—
Day Range
—
50-Day Avg
—
200-Day Avg
—
52W High
—
52W Low
—
Jun 25
+23.0%
Sep 25
+15.7%
Dec 25
+8.8%
Mar 26
+15.8%
Beat estimates 4 of 4 quarters (100%)
Sector
Healthcare
Industry
Health Care Services
HHS Scrutiny And Primary Care Expansion Shape CVS Health Investor Questions
Mizuho Raises CVS Health (CVS) Price Target on More Stable Policy Environment
Closed Rite Aid stores get surprising retail replacement
3 Ridiculously Cheap Healthcare Stocks to Buy in June
MOH Wins Illinois Medicaid Contract, Reinforcing Long-Term Stability
Leaving Las Vegas: How to Beat the House as the Stock Market Turns Into a Casino
UnitedHealth, FTC reach proposed settlement in insulin case
CVS Health (CVS): Buy, Sell, or Hold Post Q1 Earnings?